We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

TXN:NASDAQTexas Instruments Incorporated Analysis

Data as of 2026-03-09 - not real-time

$196.20

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Texas Instruments is trading at $196.2, well above its DCF fair value of $107.5, indicating a sizable premium. The stock sits just above the 20‑day SMA of 213.8 and the 50‑day SMA of 203.1, while the 200‑day SMA remains at 190.0, suggesting a short‑term pull‑back risk despite a bullish overall trend. Technical momentum is mixed: RSI is at 35 (near oversold), but the MACD histogram is negative and the signal line is bearish, flagging potential downside pressure toward the support level of $189.7. Fundamentals show solid revenue growth of 10.4% YoY, strong gross (57%) and operating (34%) margins, but free cash flow is slightly negative and the payout ratio exceeds 100%, raising dividend sustainability concerns. Valuation metrics are high – trailing P/E of 36 versus an industry average of 36.9 and forward P/E of 24.8 – positioning the stock as a growth‑oriented, possibly overvalued play. The market sentiment is extremely bullish, reflected by a Fear & Greed Index of Extreme Greed, yet volatility is elevated at 38.9% over 30 days and beta exceeds 1.3, underscoring heightened risk.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price is near technical support at $189.7
  • RSI suggests potential bounce but MACD remains bearish
  • High valuation premium limits upside in the near term

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Revenue growth of 10% and strong margins support earnings stability
  • Negative free cash flow and high debt-to-equity increase financial risk
  • Analyst median target (~$226) implies modest upside but valuation remains stretched

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Strategic partnership with NVIDIA expands high‑growth robot and AI markets
  • Analog semiconductor demand remains resilient and defensive
  • Capital management focus on free cash flow per share aims to improve dividend sustainability

Key Metrics & Analysis

Financial Health

Revenue Growth10.40%
Profit Margin28.28%
P/E Ratio36.0
ROE30.15%
ROA10.93%
Debt/Equity90.82
P/B Ratio10.9
Op. Cash Flow$7.2B
Free Cash Flow$-300624992
Industry P/E36.8

Technical Analysis

TrendBullish
RSI35.1
Support$189.70
Resistance$231.32
MA 20$213.82
MA 50$203.05
MA 200$189.97
MACDBearish
VolumeStable
Fear & Greed Index100

Valuation

Fair Value$107.54
Target Price$221.55
Upside/Downside12.92%
GradeOvervalued
TypeGrowth
Dividend Yield2.94%

Risk Assessment

Beta1.33
Volatility38.91%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.